• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    DexCom, Inc. - Common Stock (NQ:DXCM)

    58.22 -9.98 (-14.63%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about DexCom, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    39 40 Next >
    DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor
    Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify. 
    Via Benzinga
    Topics Death Lawsuit
    Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices
    Short seller Hunterbrook stated that at least 13 G7 users have died since the device launched in 2023. 
    Via Stocktwits
    Topics Death Economy
    Dexcom Appoints Euan Ashley to Board of Directors
    From DexCom, Inc.
    Via Business Wire
    Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via Business Wire
    DexCom Stock Slumps 10% After Hunterbrook Media Investigation Raises Concerns About Its G7 Device
    Via Stocktwits
    Forecasting The Future: 13 Analyst Projections For DexCom
     
    Via Benzinga
    2 Stocks Down 17% and 21% to Buy Right Now
    Both companies have faced recent challenges, but look likely to overcome them. 
    Via The Motley Fool
    Topics World Trade
    Q2 Earnings Roundup: DexCom (NASDAQ:DXCM) And The Rest Of The Patient Monitoring Segment
    Let’s dig into the relative performance of DexCom (NASDAQ:DXCM) and its peers as we unravel the now-completed Q2 patient monitoring earnings season. 
    Via StockStory
    Topics Artificial Intelligence
    Dexcom Inc (NASDAQ:DXCM) Fits the Affordable Growth Strategy with Solid Expansion and Sensible Pricing
    Dexcom offers strong growth in diabetes care with solid profitability and a reasonable valuation, fitting an affordable growth investment strategy. 
    Via Chartmill
    DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know
    A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
    Via StockStory
    Topics Economy Government World Trade
    1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm
    A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
    Via StockStory
    Dexcom Schedules Third Quarter 2025 Earnings Release and Conference Call for October 30, 2025 at 4:30 p.m. Eastern Time.
    From DexCom, Inc.
    Via Business Wire
    Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
    Wall Street posts modest gains as shutdown begins and jobs data disappoints, but optimism around earnings and rate cuts keeps markets afloat. 
    Via Benzinga
    Which S&P500 stocks are moving on Wednesday?
    Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
    Via Chartmill
    What's going on in today's session: S&P500 gap up and gap down stocks
    Let's have a look at the S&P500 gap up and gap down stocks in today's session. 
    Via Chartmill
    Stay informed with the top movers within the S&P500 index on Friday.
    Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
    Via Chartmill
    Forecasting The Future: 10 Analyst Projections For DexCom
    10 analysts have expressed a variety of opinions on DexCom (NASDAQ: DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. 
    Via Benzinga
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DexCom, Inc. - DXCM
    From Pomerantz LLP
    Via GlobeNewswire
    1 Growth Stock Down 40% to Buy Hand Over Fist Right Now
    It is dealing with some short-term issues, but its prospects remain bright. 
    Via The Motley Fool
    Topics World Trade
    2 Mid-Cap Stocks with Promising Prospects and 1 Facing Challenges
    Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
    Via StockStory
    Topics Economy
    Which Stocks Win When Rates Fall? Goldman Picks These Surprising Names
     
    Via Benzinga
    Darden, Humana, And Rocket Lab Are Among Top 10 Large Cap Losers Last Week (Sep. 15- Sep. 19): Are The Others In Your Portfolio?
    Darden, Humana, Rocket Lab, and FactSet led last week's large-cap losers, with declines driven by weak earnings, guidance, and downgrades. 
    Via Benzinga
    DEXCOM INC (NASDAQ:DXCM) Fits the Affordable Growth Investment Strategy
    DexCom (DXCM) offers strong growth, high profitability, and reasonable valuation, fitting the "Affordable Growth" investment strategy for long-term gains. 
    Via Chartmill
    The Healthcare Horizon: Navigating Innovation, Policy Shifts, and Evolving Patient Care
    The global healthcare industry is currently in the midst of a profound metamorphosis, characterized by a rapid influx of technological innovation, significant shifts in policy, and evolving patient... 
    Via MarketMinute
    Topics Artificial Intelligence
    Friday's session: top gainers and losers in the S&P500 index
    Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
    Via Chartmill
    Small-Cap and Value Stocks Stage a Powerful Comeback: A Market Rebalancing Act Underway
    After years of being overshadowed by their large-cap growth counterparts, small-cap and value stocks are experiencing a significant resurgence, signaling a potential seismic shift in market leadership.... 
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    Wall Street Extends Gains, Apple Jumps To Highest Since February: What's Moving Markets Friday?
    Wall Street kept driving equity valuations higher on Friday, extending the momentum from Thursday when all major U.S. benchmarks closed at record highs following the Federal Reserve's rate cut. 
    Via Benzinga
    Topics Economy
    Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
    Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. 
    Via Chartmill
    Uncover the latest developments among S&P500 stocks in today's session.
    Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday. 
    Via Chartmill
    Why DexCom (DXCM) Shares Are Trading Lower Today
    Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring... 
    Via StockStory
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    39 40 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.